Pilgrim Hospital is a hospital in the east of Lincolnshire on the A16, north of the town of Boston near the mini-roundabout with the A52. It is situated virtually on the Greenwich Meridian and adjacent to Boston High School.

There are 391 beds in Pilgrim Hospital.

During the past decade, Pilgrim Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pilgrim Hospital" #1 sponsor was "Coloplast A/S" with 3 trials, followed by "Institute of Cancer Research, United Kingdom" with 3 trials sponsored, "University College, London" with 3 trials sponsored, "Royal Liverpool University Hospital" with 2 trials sponsored and "University of Leeds" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pilgrim Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "LifeCell" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Pilgrim Hospital" are "Breast Cancer" (4 trials), "Cervical Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Colostomy" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Pilgrim Hospital" in a lesser frequency.

Most popular intervention types in "Pilgrim Hospital" are "Drug" (15 trials), "Device" (5 trials), "Procedure" (3 trials), "Radiation" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "adjuvant therapy" (2 trials), "capecitabine" (2 trials), "Abemaciclib" (1 trials) and "Arm A Mylotarg plus DA Versus CPX-351" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pilgrim Hospital" are 20 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Pilgrim Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Pilgrim Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Pilgrim Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".